MyChesCo on MSN1d
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
Fierce Pharma6d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
New Atlas1d
First new stroke and UTI drugs in 30 years get FDA approval
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
PharmExec5d
FDA Approves GSK’s Blujepa for Uncomplicated Urinary Tract Infections
Blujepa marks the first new oral antibiotic to gain FDA approval for uncomplicated urinary tract infections in nearly 30 ...
Can GSK's Blujepa provide relief from UTIs amid rising bacterial resistance and declining treatment efficacy?
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...
US FDA greenlights GSK's drug for UTIs in women and girls
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
GSK's Blujepa Approved For Treatment of UTIs in Women, Children
GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...
GSK confirms Blujepa approved by FDA for uUTIs
GSK (GSK) plc announced that the U.S. Food and Drug Administration has approved Blujepa for the treatment of female adults and pediatric ...
Yahoo Finance6d
FDA approves GSK’s Blujepa for uncomplicated UTIs
The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for treating uncomplicated urinary tract infections (uUTIs) in adult females ...
Medical Dialogues6d
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and older
London: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa ...
FDA greenlights GSK’s drug for UTIs in women and girls
The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...